You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NALOXONE HYDROCHLORIDE (AUTOINJECTOR) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Naloxone Hydrochloride (autoinjector), and when can generic versions of Naloxone Hydrochloride (autoinjector) launch?

Naloxone Hydrochloride (autoinjector) is a drug marketed by Kaleo Inc and is included in one NDA. There are eighteen patents protecting this drug.

This drug has one hundred and forty-one patent family members in fifteen countries.

The generic ingredient in NALOXONE HYDROCHLORIDE (AUTOINJECTOR) is naloxone hydrochloride. There are twelve drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Naloxone Hydrochloride (autoinjector)

A generic version of NALOXONE HYDROCHLORIDE (AUTOINJECTOR) was approved as naloxone hydrochloride by HOSPIRA on September 24th, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)?
  • What are the global sales for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)?
  • What is Average Wholesale Price for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)?
Drug patent expirations by year for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Recent Clinical Trials for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 1
National Institute on Drug Abuse (NIDA)Phase 1

See all NALOXONE HYDROCHLORIDE (AUTOINJECTOR) clinical trials

Pharmacology for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists

US Patents and Regulatory Information for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)

NALOXONE HYDROCHLORIDE (AUTOINJECTOR) is protected by eighteen US patents.

Patents protecting NALOXONE HYDROCHLORIDE (AUTOINJECTOR)

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A DOSE OF NALOXONE

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems, and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kaleo Inc NALOXONE HYDROCHLORIDE (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 215457-001 Feb 28, 2022 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Kaleo Inc NALOXONE HYDROCHLORIDE (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 215457-001 Feb 28, 2022 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Kaleo Inc NALOXONE HYDROCHLORIDE (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 215457-001 Feb 28, 2022 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)

See the table below for patents covering NALOXONE HYDROCHLORIDE (AUTOINJECTOR) around the world.

Country Patent Number Title Estimated Expiration
Japan 4960252 ⤷  Sign Up
Mexico 2010012334 DISPOSITIVO DE ADMINISTRACION DE MEDICAMENTOS PROVISTO DE UN SISTEMA DE CIRCUITOS ELECTRONICOS. (MEDICAMENT DELIVERY DEVICE HAVING AN ELECTRONIC CIRCUIT SYSTEM.) ⤷  Sign Up
Japan 2010510000 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1685839 92292 Luxembourg ⤷  Sign Up PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.